Literature DB >> 29109296

Reply to Fattori et al.: Action of SP and IL-33 on mast cells.

Theoharis C Theoharides1,2,3, Alexandra Taracanova4,2, Irene Tsilioni4, Pio Conti5, Susan E Leeman6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29109296      PMCID： PMC5703332          DOI： 10.1073/pnas.1716233114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Alternative splicing of interleukin-33 and type 2 inflammation in asthma.

Authors:  Erin D Gordon; Laura J Simpson; Cydney L Rios; Lando Ringel; Marrah E Lachowicz-Scroggins; Michael C Peters; Agata Wesolowska-Andersen; Jeanmarie R Gonzalez; Hannah J MacLeod; Laura S Christian; Shaopeng Yuan; Liam Barry; Prescott G Woodruff; K Mark Ansel; Karl Nocka; Max A Seibold; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

2.  Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation.

Authors:  Mengmeng Zhan; Wenjiao Zheng; Qijun Jiang; Zuotao Zhao; Zhiyun Wang; Junling Wang; Huiyun Zhang; Shaoheng He
Journal:  Cell Biol Toxicol       Date:  2017-02-02       Impact factor: 6.691

3.  IL-33 in clinical practice: Size matters?

Authors:  Hideaki Morita; Susumu Nakae; Hirohisa Saito; Kenji Matsumoto
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

Review 4.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

5.  IL-33/ST2 signaling boosts inflammation and pain.

Authors:  Victor Fattori; Sergio M Borghi; Waldiceu A Verri
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

Review 6.  Of Mice, Dirty Mice, and Men: Using Mice To Understand Human Immunology.

Authors:  David Masopust; Christine P Sivula; Stephen C Jameson
Journal:  J Immunol       Date:  2017-07-15       Impact factor: 5.422

7.  SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.

Authors:  Alexandra Taracanova; Mihail Alevizos; Anna Karagkouni; Zuiy Weng; Errol Norwitz; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

8.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

9.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

10.  Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion.

Authors:  Theoharis C Theoharides; Julia M Stewart; Irene Tsilioni
Journal:  Int J Immunopathol Pharmacol       Date:  2017-05-08       Impact factor: 3.219
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.